| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ambrx Biopharma, Inc. | Chief Financial Officer | Common Stock | 0 | $0 | $9.82 | 07 Mar 2024 | Direct |
| Ambrx Biopharma, Inc. | Chief Financial Officer | Restricted Stock Units | 0 | $0 | $9.82 | 07 Mar 2024 | Direct |
| Ambrx Biopharma Inc. | Chief Financial Officer | Stock Option (right to buy) | 389,000 | 05 Jul 2023 | Direct | ||
| Motus GI Holdings, Inc. | Director | Stock Option (right to buy) | 23,205 | 05 Mar 2024 | Direct | ||
| Ambrx Biopharma, Inc. | Chief Financial Officer | Option to Purchase Common Stock | 0 | 07 Mar 2024 | Direct |